Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
This article evaluates which allocation—S&P 500 or Total Market—better supports retirement goals, with actionable insights for allocators.
28,550 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Bitcoin has tumbled as the AI boom pulls money into tech and AI-related plays. This article breaks down what capital ...
A controversial finish in the boxing world highlights how accountability, dispute resolution and strategic negotiatio...
A Massachusetts man fell for a phony online romance that morphed into a fake crypto investment. He ended up losing hu...
The Premier League Lacrosse secures a $100 million funding round, bringing in entertainment and finance power to acce...
Ally Bank Savings remains a popular online choice for those who want a straightforward, fee-free high-yield option. T...
Investors sent shares of National Energy Services Reunited higher after news of sizable cementing contracts in the Mi...
Astronics reports a mixed Q1 2026 that tests the durability of its backlog and margin recovery. This article breaks d...
A widening Epstein-related inquiry fuels renewed scrutiny of global power players. As whispers of the former Prince A...
OmniPact raises $50 million in a private round to accelerate its cross-chain trust layer. The funds will power a Q1 2...
An agreement settles customer claims against ftx’s former firm, auditor for $66 million, without admission of wrongdo...
Oil markets roiled by Hormuz disruptions push energy ETFs past the 50% mark for the year, prompting a closer look at ...